Prevalence and factors associated with chemotherapy-induced adverse events in cancer treatment centers in Amhara national regional state comprehensive referral hospitals, 2024: multicenter prospective follow up study
Atalay Eshetie Demilie, Habtu Tsehayu Bayu, Mahder Metenu Taye, Fikadu Tadesse Diress, Endale Gebreegziabher Gebremedhn · 2025
Read Prevalence and factors associated with chemotherapy-induced adverse events in cancer treatment centers in Amhara national regional state comprehensive referral hospitals, 2024: multicenter prospective follow up study by Atalay Eshetie Demilie, Habtu Tsehayu Bayu, Mahder Metenu Taye, Fikadu Tadesse Diress, Endale Gebreegziabher Gebremedhn (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12781528.txt.
Description
Atalay Eshetie Demilie and co-authors gauge how often cancer drug treatment causes harmful side effects in hospitals in the Amhara region of Ethiopia, in work from 2025. Such side effects limit care and worsen results, yet local rates were not well mapped. The study followed patients forward in time across centers.
In all, 572 patients took part, and about seventy-eight percent had at least one side effect. Events were graded on a standard cancer scale. One drug, cisplatin, stood out for the share of events tied to it. The team weighed which traits raised the odds of harm. They argue that knowing local rates and risk traits can guide safer dosing and closer watch of high-risk patients.
Catalog record
| CREATOR | Atalay Eshetie Demilie, Habtu Tsehayu Bayu, Mahder Metenu Taye, Fikadu Tadesse Diress, Endale Gebreegziabher Gebremedhn |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |